3. Palatin Technologies Corporate Update: Palatin Technologies provided a corporate update, highlighting its key accomplishments in 2023 and anticipated clinical development milestones for 2024. The company's focus areas include Dry Eye Disease, Ulcerative Colitis, Obesity, and Male Sexual Dysfunction.3 Topline data readout for the Phase 3 PL9643 clinical study for DED is expected early in the first quarter of 2024.3